993 results on '"Zeiser, Robert"'
Search Results
2. Correction: Real‑world data suggest effectiveness of the allogeneic mesenchymal stromal cells preparation MSC‑FFM in ruxolitinib‑refractory acute graft‑versus‑host disease
3. Prostaglandin E2 controls the metabolic adaptation of T cells to the intestinal microenvironment
4. ROCK1/2 signaling contributes to corticosteroid-refractory acute graft-versus-host disease
5. Multiomic spatial landscape of innate immune cells at human central nervous system borders
6. A new silicon phthalocyanine dye induces pyroptosis in prostate cancer cells during photoimmunotherapy
7. The MAGIC algorithm probability predicts treatment response and long-term outcomes to second-line therapy for acute GVHD
8. Long-term follow-up of patients with acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation after primary induction failure
9. Real-world data suggest effectiveness of the allogeneic mesenchymal stromal cells preparation MSC-FFM in ruxolitinib-refractory acute graft-versus-host disease
10. Flares of acute graft-versus-host disease: a Mount Sinai Acute GVHD International Consortium analysis
11. Granulocyte-Macrophage Colony-Stimulating Factor in Allogenic Hematopoietic Stem Cell Transplantation: From Graft-versus-Host Disease to the Graft-versus-Tumor Effect
12. Outcomes of haploidentical transplants with PT-CY vs 10/10 MUD transplants with ATG in Germany
13. GPRC5C drives branched-chain amino acid metabolism in leukemogenesis
14. Activated granulocytes and inflammatory cytokine signaling drive T-cell lymphoma progression and disease symptoms
15. Reg3α concentrations at day of allogeneic stem cell transplantation predict outcome and correlate with early antibiotic use
16. Prognostic value of blood biomarkers in steroid-refractory or steroid-dependent acute graft-versus-host disease: a REACH2 analysis
17. Retinoic acid signaling acts as a rheostat to balance Treg function
18. Donor and host B7-H4 expression negatively regulates acute graft-versus-host disease lethality
19. Dendritic Cell Expression of Retinal Aldehyde Dehydrogenase-2 Controls Graft-versus-Host Disease Lethality
20. Fever supports CD8⁺ effector T cell responses by promoting mitochondrial translation
21. Targeting MDM2 enhances antileukemia immunity after allogeneic transplantation via MHC-II and TRAIL-R1/2 upregulation
22. Toward a Better Understanding of the Atypical Features of Chronic Graft-Versus-Host Disease: A Report from the 2020 National Institutes of Health Consensus Project Task Force
23. Three US Food and Drug Administration–approved therapies for chronic GVHD
24. Editorial: Transcriptional and epigenetic regulation in normal and aberrant hematopoiesis
25. Coevolving JAK2V617F+relapsed AML and donor T cells with PD-1 blockade after stem cell transplantation: an index case
26. The impact of pulmonary function in patients undergoing autologous stem cell transplantation
27. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2020 Treatment of Chronic GVHD Report
28. Repurposing a novel anti-cancer RXR agonist to attenuate murine acute GVHD and maintain graft-versus-leukemia responses
29. Acute Graft-Versus-Host Disease
30. The development of ruxolitinib for glucocorticoid-refractory acute graft-versus-host disease
31. Flares of Acute Graft-Versus-Host Disease (GVHD): A Mount Sinai Acute GVHD International Consortium (MAGIC) Analysis
32. Effects of Concomitant Azoles on Ruxolitinib Treatment in Patients with Acute Graft-Versus-Host Disease: A Post Hoc Analysis from the Randomized Phase 3 REACH2 Study
33. Effects of Concomitant Azoles on Ruxolitinib Treatment in Patients with Chronic Graft-Versus-Host Disease: A Post Hoc Analysis from the Randomized Phase 3 REACH3 Study
34. The Mount Sinai Acute Gvhd International Consortium (MAGIC) Model: An Integrated Clinical and Biomarker Grading System for Acute Graft-Versus-Host Disease (GVHD)
35. The MAGIC Algorithm Probability Predicts Treatment Response and Long-Term Outcomes to Second-Line Therapy for Acute Gvhd
36. Interferon regulatory factor 4 plays a pivotal role in the development of aGVHD-associated colitis
37. Splicing factor YBX1 mediates persistence of JAK2-mutated neoplasms
38. Immunization against poly- N -acetylglucosamine reduces neutrophil activation and GVHD while sparing microbial diversity
39. Demethylating therapy increases anti-CD123 CAR T cell cytotoxicity against acute myeloid leukemia
40. Loss of the Fanconi anemia-associated protein NIPA causes bone marrow failure
41. Graft-versus-host disease of the CNS is mediated by TNF upregulation in microglia
42. Danger-associated extracellular ATP counters MDSC therapeutic efficacy in acute GVHD
43. Changes in Immunosuppressive Treatment of Chronic Graft-versus-Host Disease: Comparison of 2 Surveys within Allogeneic Hematopoietic Stem Cell Transplant Centers in Germany, Austria, and Switzerland
44. Prevention of CMV/EBV reactivation by double-specific T cells in patients after allogeneic stem cell transplantation: results from the randomized phase I/IIa MULTIVIR-01 study
45. Novel therapies for graft versus host disease with a focus on cell therapies
46. Novel developments in the prophylaxis and treatment of acute GVHD
47. High Mortality of COVID-19 Early after Allogeneic Stem Cell Transplantation: A Retrospective Multicenter Analysis on Behalf of the German Cooperative Transplant Study Group
48. Neutrophils provide cellular communication between ileum and mesenteric lymph nodes at graft-versus-host disease onset
49. B-cell targeting in chronic graft-versus-host disease
50. Absence of NKG2D ligands defines leukaemia stem cells and mediates their immune evasion
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.